Citation Impact
Citing Papers
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II)
2011
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
2012
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Long‐term clinical outcomes after sirolimus‐eluting stent implantation for treatment of restenosis within bare‐metal versus drug‐eluting stents
2008
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization
2010
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
2010
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Serious renal dysfunction after percutaneous coronary interventions can be predicted
2007
Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: Insights from the Dartmouth Dynamic Registry
2008
Acute kidney injury
2012 Standout
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
2006
Plaque Distribution Patterns in Distal Left Main Coronary Artery to Predict Outcomes After Stent Implantation
2010
Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
2009
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
2007
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
2009
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study
2008
Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis
2009
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
2009
Clinical Efficacy of Drug-Eluting Stents in Diabetic Patients
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Mini-Crush Versus T-Provisional Techniques in Bifurcation Lesions
2009
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
2008
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation
2008
Pathology of Drug-Eluting Stents in Humans
2006 Standout
The Relative Renal Safety of Iodixanol Compared With Low-Osmolar Contrast Media
2009
Oral Anticoagulant Therapy
2012 Standout
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials
2012
Stent Thrombosis
2010
Comparison of Coronary Artery Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left Main Coronary Artery Stenosis
2008
New Antithrombotic Drugs
2012
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial
2011
Acute kidney injury with iodinated contrast
2008
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
2012
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels
2007
Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy
2010
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
2014
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines
2011
Prevention, Incidence, and Outcomes of Contrast-Induced Acute Kidney Injury
2008
Comparison of bypass surgery with drug‐eluting stents for diabetic patients with multivessel disease
2007
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
2007
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Combining Antiplatelet and Anticoagulant Therapies
2009
Prevention of Contrast-Induced AKI
2013
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Contrast-Induced Acute Kidney Injury
2016
Comparison of Drug-Eluting Stents Versus Surgery for Unprotected Left Main Coronary Artery Disease
2007
Antithrombotic Therapy for VTE Disease
2012 Standout
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
2008
Acute kidney injury
2019 Standout
Sodium Bicarbonate is Associated with an Increased Incidence of Contrast Nephropathy
2007
Antiplatelet Drugs
2012
Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention
2010
Executive Summary
2012 Standout
Sodium Bicarbonate for the Prevention of Contrast Induced-Acute Kidney Injury
2009
Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization
2008
Cardiorenal Syndrome
2008 Standout
Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials
2009
Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis
2009
Clinical and Angiographic Outcomes After Percutaneous Recanalization of Chronic Total Saphenous Vein Graft Occlusion Using Modern Techniques
2010
Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
2011
Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)
2006
Bladder cancer
2016 Standout
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >=75 years)
2007
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies
2010
A Meta-Analysis of 3,773 Patients Treated With Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Coronary Artery Stenosis
2009
Rapamycin confers preconditioning-like protection against ischemia–reperfusion injury in isolated mouse heart and cardiomyocytes
2006
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
2013 Standout
Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting
2010
A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions
2011
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease.☆Insights from the SYNTAX run-in phase
2006
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
2014 Standout
Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations
2010
Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting
2008
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Primary and Secondary Prevention of Cardiovascular Disease
2012
Third Universal Definition of Myocardial Infarction
2012 Standout
Comparison of Percutaneous Versus Surgical Revascularization of Severe Unprotected Left Main Coronary Stenosis in Matched Patients
2007
Outcome After Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease
2008
Unprotected left main revascularization in patients with acute coronary syndromes
2009
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
2010
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
2010
Challenges in the management of acute peptic ulcer bleeding
2013
Medication Adherence: WHO Cares?
2011 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
2012 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Prevention of Contrast-Induced Nephropathy with Volume Expansion
2007
Radiocontrast-Induced Acute Kidney Injury
2008
Drug-Eluting Stents in the Real World: How Intravascular Ultrasound Can Improve Clinical Outcome
2008
5-Year Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Lesions
2010
Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
2007
Predictors of Coronary Stent Thrombosis
2009
Trends in Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions
2007
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
In-Stent Restenosis in the Drug-Eluting Stent Era
2010
Contrast-Induced Acute Kidney Injury
2008
Sodium Bicarbonate Plus N-Acetylcysteine Prophylaxis
2009
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Iodixanol Versus Low-Osmolar Contrast Media for Prevention of Contrast Induced Nephropathy
2010
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Sodium Bicarbonate Improves Long-Term Clinical Outcomes Compared With Sodium Chloride in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
2008
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery
2007
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
2009
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
2008
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
2014
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
2010
Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease
2008
Guidelines for the Primary Prevention of Stroke
2014 Standout
Cardiac Angiography in Renally Impaired Patients (CARE) Study
2007
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy
2008
Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions
2010
Contrast-induced nephropathy: the wheel has turned 360 degrees
2008
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents
2012
Results and Predictors of Angiographic Restenosis and Long-Term Adverse Cardiac Events After Drug-Eluting Stent Implantation for Aorto-Ostial Coronary Artery Disease
2007
Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation
2010
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Part 8: Post–Cardiac Arrest Care
2015 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Vascular Responses to Drug Eluting Stents
2007
Sodium Bicarbonate Therapy for the Prevention of Contrast-Induced Acute Kidney Injury
2012
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
2012
Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?
2009
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
2009
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents
2009
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of John Cosgrave being referenced
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment
2007
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL)
2007
Treatment of saphenous vein graft lesions with drug-eluting stents
2005
Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation†
2005
Early Outcome of Treatment of Ostial De Novo Left Anterior Descending Coronary Artery Lesions With Drug-Eluting Stents
2005
Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary Practice
2007
Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations
2008
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions
2005
Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique
2005
Drug-Eluting Stent Restenosis
2006
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
2008
Inflammatory markers are not associated with outcomes following elective external cardioversion
2005
Late Restenosis Following Sirolimus-Eluting Stent Implantation
2007
Frequency of Slow Coronary Flow Following Successful Stent Implantation and Effect of Nitroprusside
2007
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral Anticoagulation
2008
Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent
2007
Comparison of the Long-Term Safety and Efficacy of Drug-Eluting and Bare-Metal Stent Implantation in Saphenous Vein Grafts
2010
Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis
2006
Clinical Outcome Following Aleatory Implantation of Paclitaxel-Eluting or Sirolimus-Eluting Stents in Complex Coronary Lesions
2005
Response to Letter Regarding Article, “Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies”
2007
Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery
2006